How many drugs treat Small intestine cancer?

Drug Landscape tracks 5 marketed treatments for Small intestine cancer (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/small-intestine-cancer.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Small intestine cancer — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Small intestine cancer (disease) competitive landscape: 5 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

5 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Small intestine cancer, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Fusilev	Levofolinic acid	Spectrum Pharms	Folate Analog		2008-01-01
Fusilev	levoleucovorin	Acrotech Biopharma	Folate Analog		2008-01-01
Eloxatin	Oxaliplatin	Yakult Honsha	Platinum-based chemotherapy agent	DNA	2002-01-01
Carac	5-fu	Spectrum Pharms	Nucleoside Metabolic Inhibitor	Aromatase	1962-01-01
Carac	fluorouracil	Extrovis	Nucleoside Metabolic Inhibitor [EPC]	Aromatase	1962-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Spectrum Pharms · 2 drugs in Small intestine cancer
Acrotech Biopharma · 1 drug in Small intestine cancer
Extrovis · 1 drug in Small intestine cancer
Yakult Honsha · 1 drug in Small intestine cancer

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Small intestine cancer:

Cite this brief

Drug Landscape (2026). Small intestine cancer — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/small-intestine-cancer. Accessed 2026-06-10.

Small intestine cancer full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing